Seminario Científico dr. Lluís Montoliu 'Herramientas CRISPR en la investigación sobre la COVID-19'.
Posted by btwatson on July 14, 2020 4:36 am
Tags:
Categories:
Crispr-youtube
Seminario Científico dr. Lluís Montoliu 'Herramientas CRISPR en la investigación sobre la COVID-19'.
Seminario Científico 26/06/2020. El doctor Lluís Montoliu, investigador científico del dpto. de Biología Molecular y Celular del Centro Nacional de Biotecnologia …
Crispr News
-
Pharmalittle: Merck closes in on acquisition of Seagen; Intercept declares victory after re-analyzing NASH data - STATJuly 7, 2022
-
With 'do-over' NASH results, Intercept will seek approval for first-ever treatment for fatty liver condition - STATJuly 7, 2022
-
Virginia Retirement Systems ET AL Boosts Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - Defense WorldJuly 7, 2022
-
Functional Sugar for Food & Beverage Market Size, Share And Forecast to 2028 |BBI Life Sciences, Bio Basic, CRISPR Therapeutics, Caribou Biosciences, DNA 2.0 (ATUM) – Designer Women - Designer WomenJuly 7, 2022
-
Ataxia Market Key Vendors, Opportunities, Deep Analysis By Regional & Country Outlook | Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, …. – Designer Women - Designer WomenJuly 7, 2022
-
Non-CRISPR Gene Editing Platforms Make the Cut … or Avoid Making It - Genetic Engineering & Biotechnology NewsJuly 7, 2022
-
Base Editing: A Strong Contender in Cell and Gene Therapy - Genetic Engineering & Biotechnology NewsJuly 7, 2022
-
Climate change-fighting rice? Plants trap carbon dioxide as they grow — and CRISPR gene editing can optimize this process - Genetic Literacy ProjectJuly 7, 2022
-
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Gene-Editing Market Report Covers Future Trends With Research 2022-2028 – Designer Women - Designer WomenJuly 6, 2022
-
Tropic Biosciences Raises $35M For Gene-Editing & RNAi Platform Aimed at Developing Tropical Crops - The SpoonJuly 6, 2022
-
A time-resolved, multi-symbol molecular recorder via sequential genome editing - Nature.comJuly 6, 2022
-
A potential danger of CRISPR gene editing—and why base editing may be safer - Phys.orgJuly 6, 2022
-
Global CRISPR and CRISPR-associated (Cas) Genes Market Report 2022-2027 - Growing Investments in R&D Programs by Biotechnology Companies and Non-Profit Organizations - ResearchAndMarkets.com - Business WireJuly 6, 2022
-
Making CRISPR hype more of a reality - Phys.orgJuly 6, 2022
-
Never Mind the PTAB—Agilent is Pushing to Enjoin Competitor's CRISPR Sales | The Recorder - Law.comJuly 6, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech